Sort by
Letter to Shareholders, Notice of AGM & Proxy Form
Actinogen receives $10.8m R&D tax incentive rebate from ATO
ACW pivotal Alzheimers trial database lock - results mid-Nov
ACW September 2026 quarterly activity report & Appendix 4C
Notification of buy-back - ACW
AGM date and closing date for director nominations
Application for quotation of securities - ACW
Options underwriting cleansing notice
Application for quotation of securities - ACW
Underwriting of unlisted options completed
| Date | Headline |
|---|---|
28 Oct 2026 | Letter to Shareholders, Notice of AGM & Proxy Form |
26 Oct 2026 | Actinogen receives $10.8m R&D tax incentive rebate from ATO |
21 Oct 2026 | ACW pivotal Alzheimers trial database lock - results mid-Nov |
19 Oct 2026 | ACW September 2026 quarterly activity report & Appendix 4C |
12 Oct 2026 | Notification of buy-back - ACW |
9 Oct 2026 | AGM date and closing date for director nominations |
30 Sep 2026 | Application for quotation of securities - ACW |
23 Sep 2026 | Options underwriting cleansing notice |
23 Sep 2026 | Application for quotation of securities - ACW |
23 Sep 2026 | Underwriting of unlisted options completed |